Related to Supreme Court Rules Against Stanford in Patent Dispute with Roche over HIV Test

• Roche to Provide HIV/AIDS Tests in South Africa for Early Infant Diagnosis
  
• Court of Appeals Rules that Myriad's Patents on BRCA Genes Are Valid
  
• EC Approves Roche’s RoActemra for Treating Active Systemic Juvenile Idiopathic Arthritis
  
• FDA Green-Lights Roche’s Melanoma Drug and Companion Diagnostic
  
• PerkinElmer to Take Over Distribution of NimbleGen CGX Cytogenetics Array Workflow from Roche
  
• Researchers Find Potential New Therapeutics for Certain Protein-Folding Diseases
  
• EC Clears Roche’s Tarceva as Monotherapy Against Metastatic NSCLC with EGFR Mutations
  
• Roche Pays Evotec $10M Up Front in Deal to Develop MAO-B Inhibitor for Alzheimer Disease
  
• Roche Establishes Links with Swedish Academic Innovation Initiative
  
• Roche Wins First Major European Public Tender for HPV Test in Primary Cervical Cancer Screening
  
• Roche Acquires License to Nanopore Technology with Sights on $1,000 Whole Genome Sequencing
  
• Roche Buys HCV Therapeutics Firm Anadys for $230M in Cash
  
• European Court Bans Patents Based on Embryo Destruction
  
• Roche Gives Arrowhead RNAi Assets and Facility in Madison, WI
  
• Amylin to Pay Lilly $250M to End Exenatide Partnership and Litigation
  
• Roche and Aileron Pin Third Program to Stapled Peptide Drug Collaboration
  
• FDA Revokes Avastin Indication for Treatment of Metastatic Breast Cancer
  
• Roche Nabs PTC’s SMA Program for $30M Up Front
  
• Two-to-One Majority Differs with European Court Ruling Against Patenting hESCs
  
• Roche’s Cobas EGFR Mutation Test Granted CE Mark